TrialHaemophilia : the official journal of the World Federation of Hemophilia2021

PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.

Miguel Escobar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.